Comprehensive study on associations between nine SNPs and Glioma Risk

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 4905-4908

  Liu, Hai Bo ^a,b   Peng, Yu Ping ^a   Dou, Chang Wu ^b   Su, Xiu Lan ^b   Gao, Nai Kang ^b   Tian, Fu Ming ^b   Bai, Jie ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

EGRF; Glioma risk; SNPs; XRCC1; XRCC3

Indexed keywords

EID: 84874007005     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.4905     Document Type: Article

References (32)

1. Andersson U, Schwartzbaum J, Wiklund F, et al (2010). A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol, 49, 767-75.
2. Bondy ML, Scheurer ME, Malmer B, et al (2008). Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer, 113, 1953-68.
3. Custódio AC, Almeida LO, Pinto GR, et al (2011). Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas. Genet Mol Res, 10, 1120-9.
4. Felini MJ, Olshan AF, Schroeder JC, et al (2007). DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology, 29, 55-8.
5. Gabriel S, Ziaugra L, Tabbaa D (2009). SNP genotyping using the Sequenom MassARRAY iPLEX platform. Current Protocols in Human Genetics, Chapter 2, Unit 2, 12.
6. Kiuru A, Lindholm C, Heinävaara S, et al (2008). XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol, 88, 135-42.
7. Kharrat N, Al'Fadhli S, Rebai M, et al (2007). (AC) dinucleotide repeat polymorphism in intron 1 of human EGFR shows ethnic specificities and high evidence for association with breast cancer. Int J Biol Markers, 22, 258-64.
8. Han B, Zhou X, Zhang RX, et al. Mutations of the epidermal growth factor receptor gene in NSCLC patients. Oncol Lett, 2, 1233-7.
9. Hedman H, Henriksson R (2007). LRIG inhibitors of growth factor signallingdouble- edged swords in human cancer?Eur J Cancer, 43, 676-82.
10. He SY, Xu L, Niu G, et al (2012). Predictive Value of Excision Repair Cross-complementing Rodent Repair Deficiency Complementation Group 1 and Ovarian Cancer Risk. Asian Pac J Cancer Prev, 13, 1799-802.
11. Hou WG, Ai WB, Bai XG, et al(2012). Genetic variation in the EGFR gene and the risk of glioma in a Chinese Han population. PLoS ONE, 7, e37531.
12. Hu XB, Feng Z, Fan YC, et al (2011). Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to glioma. Asian Pac J Cancer Prev, 12, 2981-4.
13. Lee SA, Lee KM, Park SK, et al (2007). Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies. Breast Cancer Res Treat, 103, 71-6.
14. Liu Y, Chen H, Chen L, et al (2012). Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population. Hepatogastroenterology, 59, 977-80.
15. McWilliams RR, Bamlet WR, Cunningham JM, et al (2008). Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res, 68, 4928-35.
16. Parkin DM, Bray F, Ferlay J, et al (2005) Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
17. Perez CA, Chen H, Shyr Y, et al (2010). The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer. J Urol, 183, 2062-9.
18. Rajaraman P, Melin BS, Wang Z, et al (2012). Genome-wide association study of glioma and meta-analysis. Hum Genet.
19. Sadetzki S, Chetrit A, Freedman L, et al (2005). Long-term follow-up for brain tumor development after childhood exposure to ionizing radiation for tinea capitis. Radiat Res, 164, 424-32.
20. Sreeja L, Syamala VS, Syamala V, et al (2008). Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol, 134, 645-52.
21. Thomas RK, Baker AC, Debiasi RM, et al (2007). High-throughput oncogene mutation profiling in human cancer. Nature Genetics, 39, 347-51.
22. Tokunaga A, Onda M, Okuda T, et al (1995). Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Cancer, 75, 1418-25.
23. Upadhyay R, Jain M, Kumar S, et al (2008). Interaction of EGFR 497Arg.Lys with EGF +61A.G polymorphism: modulation of risk in esophageal cancer. Oncol Res, 17, 167-74.
24. Wrensch M, Jenkins RB, Chang JS, et al (2009). Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nature Genetics, 41, 905-8.
25. Wang N, Wu Y, Zhou X, et al (2012). Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population. Wei Sheng Yan Jiu, 41, 251-6.
26. Wen YY, Pan XF, Loh M, et al (2012). ADPRT Val762Ala and XRCC1 Arg194Trp Polymorphisms and Risk of Gastric Cancer in Sichuan of China. Asian Pac J Cancer Prev, 13, 2139-44.
27. Wong AJ, Ruppert JM, Bigner SH, et al (1992). Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A, 89, 2965-9.
28. Wrensch M, Kelsey KT, Liu M, et al(2004). Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev, 13, 461-7.
29. Yao L, Ji G, Gu A, et al(2012). An updated pooled analysis of glutathione S-transferase genotype polymorphisms and risk of adult gliomas. Asian Pac J Cancer Prev, 13, 157-63.
30. Yun J, Song SH, Park J, et al (2012). Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers. Lab Invest, 92, 1033-44.
31. Zhao Y, Deng X, Wang Z, et al (2012). Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population. Asian Pac J Cancer Prev, 13, 665-9.
32. Zhou LQ, Ma Z, Shi XF, et al (2011). Polymorphisms of DNA repair gene XRCC1 and risk of glioma: a case-control study in Southern China. Asian Pac J Cancer Prev, 12, 2547-50.